Rocket Pharmaceuticals Inc (NASDAQ: RCKT) May Be Attracting Institutional Investments

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Rocket Pharmaceuticals Inc is $2.19B. A total of 0.89 million shares were traded on the day, compared to an average of 721.30K shares.

In the most recent transaction, SOUTHWELL DAVID P sold 10,000 shares of RCKT for 24.05 per share on Apr 15 ’24. After the transaction, the Director now owns 114,784 company shares. In a previous transaction on Apr 12 ’24, SOUTHWELL DAVID P sold 70,000 shares at 24.36 per share. RCKT shares that Director owns now total 95,160.

Among the insiders who sold shares, White Mark Andrew disposed of 12,532 shares on Apr 08 ’24 at a per-share price of $24.64. This resulted in the insider holding 75,226 shares of RCKT after the transaction. In another insider transaction, Makker Gotham sold 274,000 shares at $28.43 per share on Mar 21 ’24. Company shares held by the Director now total 365,912.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, RCKT has a high of $32.53 and a low of $14.89.

As of this writing, RCKT has an earnings estimate of $Red Cat Holdings, Inc. per share for the current quarter. EPS was calculated based on a consensus of Rocket Companies, Inc. estimates, with a high estimate of $ROKT per share and a lower estimate of $Rocket Pharmaceuticals, Inc..

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. RCKT’s latest balance sheet shows that the firm has $388.74M in Cash & Short Term Investments as of fiscal 2021. There were $22.60M in debt and $22.17M in liabilities at the time. Its Book Value Per Share was $5.46, while its Total Shareholder’s Equity was $454.72M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RCKT is Buy with a score of 4.79.

Most Popular

Related Posts